Cargando…
The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis
Background and Aim: The predominant species of the Enterococcus, Enterococcus faecalis (E. faecalis) and Enterococcus faecium (E. faecium) cause great variety of infections. Therefore, the expansion of antimicrobial resistance in the Enterococcus is one of the most important global concerns. This st...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460910/ https://www.ncbi.nlm.nih.gov/pubmed/34568377 http://dx.doi.org/10.3389/fmed.2021.720647 |
_version_ | 1784571862626336768 |
---|---|
author | Dadashi, Masoud Sharifian, Parastoo Bostanshirin, Nazila Hajikhani, Bahareh Bostanghadiri, Narjess Khosravi-Dehaghi, Nafiseh van Belkum, Alex Darban-Sarokhalil, Davood |
author_facet | Dadashi, Masoud Sharifian, Parastoo Bostanshirin, Nazila Hajikhani, Bahareh Bostanghadiri, Narjess Khosravi-Dehaghi, Nafiseh van Belkum, Alex Darban-Sarokhalil, Davood |
author_sort | Dadashi, Masoud |
collection | PubMed |
description | Background and Aim: The predominant species of the Enterococcus, Enterococcus faecalis (E. faecalis) and Enterococcus faecium (E. faecium) cause great variety of infections. Therefore, the expansion of antimicrobial resistance in the Enterococcus is one of the most important global concerns. This study was conducted to investigate the prevalence of resistance to linezolid, tigecycline, and daptomycin among enterococcal strains isolated from human clinical specimens worldwide. Methods: Several databases including Web of Science, EMBASE, and Medline (via PubMed), were carefully searched and reviewed for original research articles available in databases and published between 2000 and 2020. A total of 114 studies worldwide that address E. faecalis and E. faecium resistance to linezolid, tigecycline, and daptomycin were analyzed by STATA software. Results: The overall prevalence of antibiotic-resistant E. faecalis and E. faecium was reported to be 0.9 and 0.6%, respectively. E. faecalis and E. faecium were more resistant to the linezolid (2.2%) and daptomycin (9%), respectively. The prevalence of tigecyline-resistant E. facium (1%) strains was higher than E. faecalis strains (0.3%). Accordingly, the prevalence of linezolid-resistant E. faecalis was higher in Asia (2.8%), while linezolid-resistant E. faecium was higher in the America (3.4%). Regarding tigecycline-resistance, a higher prevalence of E. faecalis (0.4%) and E. faecium (3.9%) was reported in Europe. Conclusion: In conclusion, this meta-analysis shows that there is an emerging resistance in Enterococcus strains. Despite the rising resistance of enterococci to antibiotics, our results demonstrate that tigecycline, daptomycin, and linezolid can still be used for the treatment of enterococcal infections worldwide. |
format | Online Article Text |
id | pubmed-8460910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84609102021-09-25 The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis Dadashi, Masoud Sharifian, Parastoo Bostanshirin, Nazila Hajikhani, Bahareh Bostanghadiri, Narjess Khosravi-Dehaghi, Nafiseh van Belkum, Alex Darban-Sarokhalil, Davood Front Med (Lausanne) Medicine Background and Aim: The predominant species of the Enterococcus, Enterococcus faecalis (E. faecalis) and Enterococcus faecium (E. faecium) cause great variety of infections. Therefore, the expansion of antimicrobial resistance in the Enterococcus is one of the most important global concerns. This study was conducted to investigate the prevalence of resistance to linezolid, tigecycline, and daptomycin among enterococcal strains isolated from human clinical specimens worldwide. Methods: Several databases including Web of Science, EMBASE, and Medline (via PubMed), were carefully searched and reviewed for original research articles available in databases and published between 2000 and 2020. A total of 114 studies worldwide that address E. faecalis and E. faecium resistance to linezolid, tigecycline, and daptomycin were analyzed by STATA software. Results: The overall prevalence of antibiotic-resistant E. faecalis and E. faecium was reported to be 0.9 and 0.6%, respectively. E. faecalis and E. faecium were more resistant to the linezolid (2.2%) and daptomycin (9%), respectively. The prevalence of tigecyline-resistant E. facium (1%) strains was higher than E. faecalis strains (0.3%). Accordingly, the prevalence of linezolid-resistant E. faecalis was higher in Asia (2.8%), while linezolid-resistant E. faecium was higher in the America (3.4%). Regarding tigecycline-resistance, a higher prevalence of E. faecalis (0.4%) and E. faecium (3.9%) was reported in Europe. Conclusion: In conclusion, this meta-analysis shows that there is an emerging resistance in Enterococcus strains. Despite the rising resistance of enterococci to antibiotics, our results demonstrate that tigecycline, daptomycin, and linezolid can still be used for the treatment of enterococcal infections worldwide. Frontiers Media S.A. 2021-09-10 /pmc/articles/PMC8460910/ /pubmed/34568377 http://dx.doi.org/10.3389/fmed.2021.720647 Text en Copyright © 2021 Dadashi, Sharifian, Bostanshirin, Hajikhani, Bostanghadiri, Khosravi-Dehaghi, van Belkum and Darban-Sarokhalil. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Dadashi, Masoud Sharifian, Parastoo Bostanshirin, Nazila Hajikhani, Bahareh Bostanghadiri, Narjess Khosravi-Dehaghi, Nafiseh van Belkum, Alex Darban-Sarokhalil, Davood The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis |
title | The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis |
title_full | The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis |
title_fullStr | The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis |
title_full_unstemmed | The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis |
title_short | The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis |
title_sort | global prevalence of daptomycin, tigecycline, and linezolid-resistant enterococcus faecalis and enterococcus faecium strains from human clinical samples: a systematic review and meta-analysis |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460910/ https://www.ncbi.nlm.nih.gov/pubmed/34568377 http://dx.doi.org/10.3389/fmed.2021.720647 |
work_keys_str_mv | AT dadashimasoud theglobalprevalenceofdaptomycintigecyclineandlinezolidresistantenterococcusfaecalisandenterococcusfaeciumstrainsfromhumanclinicalsamplesasystematicreviewandmetaanalysis AT sharifianparastoo theglobalprevalenceofdaptomycintigecyclineandlinezolidresistantenterococcusfaecalisandenterococcusfaeciumstrainsfromhumanclinicalsamplesasystematicreviewandmetaanalysis AT bostanshirinnazila theglobalprevalenceofdaptomycintigecyclineandlinezolidresistantenterococcusfaecalisandenterococcusfaeciumstrainsfromhumanclinicalsamplesasystematicreviewandmetaanalysis AT hajikhanibahareh theglobalprevalenceofdaptomycintigecyclineandlinezolidresistantenterococcusfaecalisandenterococcusfaeciumstrainsfromhumanclinicalsamplesasystematicreviewandmetaanalysis AT bostanghadirinarjess theglobalprevalenceofdaptomycintigecyclineandlinezolidresistantenterococcusfaecalisandenterococcusfaeciumstrainsfromhumanclinicalsamplesasystematicreviewandmetaanalysis AT khosravidehaghinafiseh theglobalprevalenceofdaptomycintigecyclineandlinezolidresistantenterococcusfaecalisandenterococcusfaeciumstrainsfromhumanclinicalsamplesasystematicreviewandmetaanalysis AT vanbelkumalex theglobalprevalenceofdaptomycintigecyclineandlinezolidresistantenterococcusfaecalisandenterococcusfaeciumstrainsfromhumanclinicalsamplesasystematicreviewandmetaanalysis AT darbansarokhalildavood theglobalprevalenceofdaptomycintigecyclineandlinezolidresistantenterococcusfaecalisandenterococcusfaeciumstrainsfromhumanclinicalsamplesasystematicreviewandmetaanalysis AT dadashimasoud globalprevalenceofdaptomycintigecyclineandlinezolidresistantenterococcusfaecalisandenterococcusfaeciumstrainsfromhumanclinicalsamplesasystematicreviewandmetaanalysis AT sharifianparastoo globalprevalenceofdaptomycintigecyclineandlinezolidresistantenterococcusfaecalisandenterococcusfaeciumstrainsfromhumanclinicalsamplesasystematicreviewandmetaanalysis AT bostanshirinnazila globalprevalenceofdaptomycintigecyclineandlinezolidresistantenterococcusfaecalisandenterococcusfaeciumstrainsfromhumanclinicalsamplesasystematicreviewandmetaanalysis AT hajikhanibahareh globalprevalenceofdaptomycintigecyclineandlinezolidresistantenterococcusfaecalisandenterococcusfaeciumstrainsfromhumanclinicalsamplesasystematicreviewandmetaanalysis AT bostanghadirinarjess globalprevalenceofdaptomycintigecyclineandlinezolidresistantenterococcusfaecalisandenterococcusfaeciumstrainsfromhumanclinicalsamplesasystematicreviewandmetaanalysis AT khosravidehaghinafiseh globalprevalenceofdaptomycintigecyclineandlinezolidresistantenterococcusfaecalisandenterococcusfaeciumstrainsfromhumanclinicalsamplesasystematicreviewandmetaanalysis AT vanbelkumalex globalprevalenceofdaptomycintigecyclineandlinezolidresistantenterococcusfaecalisandenterococcusfaeciumstrainsfromhumanclinicalsamplesasystematicreviewandmetaanalysis AT darbansarokhalildavood globalprevalenceofdaptomycintigecyclineandlinezolidresistantenterococcusfaecalisandenterococcusfaeciumstrainsfromhumanclinicalsamplesasystematicreviewandmetaanalysis |